[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354315-105":59,"doc-detail-354315-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","nitric-oxide-driven-warburg-reprogramming-at-the-nos2-cox2-axis-an-integrative-engine-of-cancer-hallmarks","Nitric oxide-driven Warburg reprogramming at the NOS2-COX2 axis: An integrative engine of cancer hallmarks","","Nitric oxide synthase 2 (NOS2) and cyclooxygenase 2 (COX2) form a critical intersection linking inflammation, metabolism, and oncogenic signaling to drive a nitric oxide (NO)-driven Warburg phenotype in advanced cancers. NOS2-derived NO inhibits OXPHOS by targeting iron-sulfur enzymes and respiratory complexes, while sustained NOS2 expression elevates glycolysis, glutamine dependence, and NADPH production. At nitrosative concentrations, NO disrupts TCA entry and disables dehydrogenase and electron transport pathways, activating HIF-1α, PI3K/Akt, ERK/PKM2/c-Myc, Nrf2, and TGF-β/SMAD signaling, locking oncogenic programs via NO-iron-epigenetic circuitry. NOS2/COX2 also reinforce a feed-forward inflammatory and immunosuppressive loop through PGE2, IL-6, and IL-8, shaping spatial microdomains with distinct vulnerabilities.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nitric-oxide-driven-warburg-reprogramming-at-the-nos2-cox2-axis-an-integrative-engine-of-cancer-hallmarks/354315/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nitric-oxide-driven-warburg-reprogramming-at-the-nos2-cox2-axis-an-integrative-engine-of-cancer-hallmarks/354315.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"How do NOS2 and COX2 cooperate to drive the Warburg phenotype in cancer?","Question",{"text":113,"@type":114},"NOS2-derived NO and COX2-linked signaling reinforce metabolic rewiring that supports a Warburg-like state. The NOS2/COX2 axis coordinates inhibition of oxidative phosphorylation and sustained activation of pro-survival oncogenic pathways.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What molecular mechanisms explain how NO disrupts cancer cell metabolism?",{"text":118,"@type":114},"At nitrosative signaling concentrations, NO breaks carbon entry into the TCA cycle and progressively disables dehydrogenase complexes and electron-transport complexes. This shifts metabolism toward high glycolytic flux with dependencies that support proliferation and biosynthesis.",{"name":120,"@type":111,"acceptedAnswer":121},"How does NO signaling lead to an epigenetic lock that maintains oncogenic programs?",{"text":122,"@type":114},"NO-iron-driven effects and metabolite-driven inhibition of TET and Jumonji demethylases stabilize oncogenic transcriptional programs. The biochemical and signaling consequences convert transient adaptation into chemically enforced dependency.",{"name":124,"@type":111,"acceptedAnswer":125},"Why is the NOS2-COX2 axis considered relevant for therapy resistance and tumor progression?",{"text":126,"@type":114},"The reciprocal NOS2/COX2 feed-forward loop promotes tumor-promoting inflammation, immunosuppression, angiogenesis, and metastasis. It also creates spatial microdomains with distinct metabolic and immune compositions that influence therapeutic vulnerabilities and resistance.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},354315,1790148650,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Redox Biology 95 (2026) 104245  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \nNitric oxide-driven Warburg reprogramming at the NOS2-COX2 axis: An integrative engine of cancer hallmarks  \nLeandro L. Coutinho a,1 , Erika M. Palmieria, Lisa A. Ridnour a, Robert Y.S. Chenga, William F. Heinz b, Stephen K. Anderson a, Timothy R. Billiarc, Jenny Chang d,  \nStephen J. Lockettb, M. Cristina Rangel f, Douglas D. Thomas e,*, Daniel W. McVicar a,** , David A. Winka,***   \na Cancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA  \nb Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USAc Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA  \nd Houston Methodist Neal Cancer Center, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX, USA e Department of Pharmaceutical Sciences, University of Illinois at Chicago, Chicago, IL, USA  \nf Center for Translational Research in Oncology, ICESP/HC, Faculdade de Medicina da Universidade de S˜ao Paulo and Comprehensive Center for Precision Oncology, Universidade de S˜ao Paulo, S˜ao Paulo, SP, 01246-000, Brazil  \nA R T I C L E I N F O  \nKeywords:  \nNitric oxide synthase 2 (NOS2) COX2-PGE2 signaling  \nWarburg effect  \nMetabolic reprogramming Tumor microenvironment (TME)  \nA B S T R A C T  \nNitric oxide synthase 2 (NOS2) and cyclooxygenase 2 (COX2) lie at a critical intersection between inflammation, metabolism, and oncogenic signaling, where they cooperatively promote and establish a Nitric Oxide (NO) -driven Warburg phenotype in advanced cancers. Early work in macrophages established NOS2-derived NO as both a signaling molecule and metabolic stressor that inhibits oxidative phosphorylation (OXPHOS) by targeting iron-sulfur enzymes and respiratory complexes, forcing neighboring cells to rewire metabolism. In human tumors, sustained NOS2 expression in cancer cells and tumor-associated macrophages (TAMs) enforces a Warburglike state characterized by high glycolytic flux, glutamine dependence, and enhanced NADPH production, supporting proliferation, biosynthesis, and resistance to oxidative stress. At nitrosative-signaling concentrations (≈100-500 nM), NO breaks carbon entry into the TCA cycle at aconitase and pyruvate dehydrogenase, progressively disables dehydrogenase complexes containing dihydrolipoamide dehydrogenase (DLD) and electrontransport complexes (ETCs), and activates hypoxia-inducible factor 1-alpha (HIF-1), phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), extracellular signal-regulated kinase (ERK)/pyruvate kinase M2 (PKM2)/c-Myc signaling axis, nuclear factor erythroid 2-related factor 2 (Nrf2), and transforming growth factor Beta (TGF-β)/SMAD pathways. These biochemical and signaling effects convert transient glycolytic adaptation into chemically enforced dependency, further stabilized by metabolite-driven inhibition of ten-eleven translocation (TET) and Jumonji demethylases, creating an “epigenetic lock” that maintains oncogenic transcriptional programs. NOS2 and COX2 form a reciprocal feed-forward circuit in which NO, prostaglandin E2 (PGE2), interleukin (IL)-6, and IL-8 reinforce one another, driving tumor-promoting inflammation, immunosuppression, angiogenesis, and metastasis while depleting nutrients and acidifying the tumor interstitial fluid. Spatially, NOS2/COX2 niches at the tumor-stroma interface and within immune deserts generate gradients of NO, PGE2, oxygen, and metabolites that partition tumors into microdomains with distinct metabolic states, immune composition, and therapeutic vulnerabilities. Integrating these insights with Hanahan's updated hallmarks of cancer, we propose that NOS2-derived NO fun","cbCaigoE3nh0chMp","https://ap.wps.com/l/cbCaigoE3nh0chMp","pdf",11888700,22,"English","# Introduction\n## Metabolic reprogramming and tumor microenvironment drivers\n## Hypoxia-selected aggressive cancer phenotypes\n# Mechanistic role of NOS2/COX2 in NO-driven Warburg reprogramming\n## NOS2-derived NO inhibition of OXPHOS and metabolic stress\n## Nitrosative signaling targets (TCA disruption, dehydrogenase and ETC inhibition)\n## Activation of oncogenic and stress-response pathways (HIF-1α, PI3K/Akt, ERK/PKM2/c-Myc, Nrf2, TGF-β/SMAD)\n# Epigenetic locking and sustained oncogenic transcription\n# Reciprocal feed-forward NOS2/COX2 circuitry and tumor-promoting inflammation\n## Effects on angiogenesis, metastasis, immunosuppression, and nutrient/acidification changes\n# Spatial microdomains and therapeutic vulnerabilities in the TME\n# Integration with cancer hallmarks and therapeutic implications","[{\"question\":\"How do NOS2 and COX2 cooperate to drive the Warburg phenotype in cancer?\",\"answer\":\"NOS2-derived NO and COX2-linked signaling reinforce metabolic rewiring that supports a Warburg-like state. The NOS2/COX2 axis coordinates inhibition of oxidative phosphorylation and sustained activation of pro-survival oncogenic pathways.\"},{\"question\":\"What molecular mechanisms explain how NO disrupts cancer cell metabolism?\",\"answer\":\"At nitrosative signaling concentrations, NO breaks carbon entry into the TCA cycle and progressively disables dehydrogenase complexes and electron-transport complexes. This shifts metabolism toward high glycolytic flux with dependencies that support proliferation and biosynthesis.\"},{\"question\":\"How does NO signaling lead to an epigenetic lock that maintains oncogenic programs?\",\"answer\":\"NO-iron-driven effects and metabolite-driven inhibition of TET and Jumonji demethylases stabilize oncogenic transcriptional programs. The biochemical and signaling consequences convert transient adaptation into chemically enforced dependency.\"},{\"question\":\"Why is the NOS2-COX2 axis considered relevant for therapy resistance and tumor progression?\",\"answer\":\"The reciprocal NOS2/COX2 feed-forward loop promotes tumor-promoting inflammation, immunosuppression, angiogenesis, and metastasis. It also creates spatial microdomains with distinct metabolic and immune compositions that influence therapeutic vulnerabilities and resistance.\"}]","Nitric oxide-driven Warburg reprogramming at the NOS2-COX2 axis: An integrative engine of cancer hallmarks | PDF",1790110045,55,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6621ebcbc7023dbcec9b6ff95d16739a.webp",983,1310,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d194e3f8cf511a9e41bf424ce5e14c4b.webp",982,1309,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8d5e2be01b84a8b200a1dfae71e7ea5.webp",981,1308,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1c6ba44b908fb077a3b7468e75a585c.webp",980,1306]